Month: March 2017
-
Challenge Seeks GI Tract Drug Delivery in Animals
A new challenge offered through InnoCentive is aiming for solutions to protect biological drugs delivered into the gastrointestinal, or GI, tract of animals.
-
Genetic Techniques Speed Brain, Muscle Cell Production
A new technology targets the expression of genes in stem cells to produce specific brain and muscle cells on demand and in a few days, a fraction of the time now required.
-
Regeneron to Sequence 500K UK Biobank Genomes
A biotech company and health database center are partnering with drug maker GlaxoSmithKline to produce genomic data on 500,000 individuals for drug discovery.
-
Univ. Spin-Off Developing Non-Toxic Bedbug Killer
Research from a lab at Pennsylvania State University led to a technology for controlling bedbug infestations with natural enemies that are harmless to humans.
-
Inhaled Drug Shown Feasible for Postpartum Bleeding
Results from a clinical trial show a dry-powder inhaled form of the drug oxytocin works in the body much like the injected form, given to prevent postpartum hemorrhage, excessive bleeding in some women after childbirth.
-
Protein IDed to Cut Implanted Device Immune Reactions
Researchers at MIT identified a protein playing a key role in promoting the scar tissue that forms from immune reactions to implanted medical devices, and blocking actions of this protein can prevent scar tissue from forming on materials often used with implants.
-
Trial to Test Gene Therapy for Inherited Eye Disease
A spin-off enterprise from University of Oxford in the U.K. began enrolling participants in a clinical trial testing gene therapy to correct a genetic eye disease.
-
Heart Assoc, Amazon Partner on Precision Medicine Data
American Heart Association and Amazon Web Services are collecting data from researchers to advance precision medicine in cardiovascular diseases and stroke.
-
Sensors, Wearables Track Moods and Eating Behavior
A system that captures and interprets spoken words by individuals and groups can track their various moods, which also predict eating behaviors leading to obesity.
-
Organ Transplant Start-Up Gains $38M in Early Funds
A one year-old company applying genome editing to make animal organs fit for human transplantation is raising $38 million its first venture funding round.